pharmaceutical investing Cynata CYP-001 Stem Cell Therapy Meets All Safety and Efficacy Endpoints in Phase 1 Trial in GvHD
Prismo Metals Announces Closing of Upsized Private Placement Silver King Exploration to Begin in July